[OH:1][CH2:2][C:3]1[CH:4]=[N:5][C:6]2[CH:7]=[C:8]3[CH2:24][C:14]4([C:22]5[C:17](=[N:18][CH:19]=[CH:20][CH:21]=5)[NH:16][C:15]4=[O:23])[CH2:13][C:9]3=[CH:10][C:11]=2[N:12]=1>C(Cl)(Cl)Cl.CO.[O-2].[Mn+4].[O-2]>[O:23]=[C:15]1[NH:16][C:17]2=[N:18][CH:19]=[CH:20][CH:21]=[C:22]2[C:14]21[CH2:13][C:9]1=[CH:10][C:11]3[N:12]=[C:3]([CH:2]=[O:1])[CH:4]=[N:5][C:6]=3[CH:7]=[C:8]1[CH2:24]2A mixture of (±)-2-(hydroxymethyl)-6,8-dihydrospiro[cyclopenta[g]quinoxaline-7,3′-pyrrolo[2,3-b]pyridin]-2′(1′H)-one from Step A (35 mg, 0.11 mmol) and manganese (IV) oxide (158 mg, 1.82 mmol) in CHCl3 (5 mL) and MeOH (0.1 mL) was heated at reflux for 18 h. The cooled mixture was filtered through a pad of Celite, washing with CH2Cl2 and MeOH, and the filtrate was concentrated in vacuo to give the title compound. MS: m/z=358 (M+1+CH3CN).